No Detail Found!

Evaluation of Iyengariastellata for its hypolipidemic and hepatoprotective activity.

Author(s)
Bushra Riaz Department of Pharmacology, Faculty of Pharmacy, Jinnah University for Women, Karachi, Karachi, Pakistan
Rahila Najam Department of Pharmacology, Faculty of Pharmacy, University of Karachi, Karachi, Pakistan
Humera Anser Department of Pharmacology, Jinnah College of Pharmacy, Karachi, Pakistan
Muhammad Shaiq Ali Research Institute of Chemistry, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, Pakistan
Abstract
Cholesterol is believed to be the major regulator involved in the formation and progression of atheroma plaque. Seaweeds are known to possess enormous biological activities. They contain variety of active constituents, which have pharmacological significance. The objective of this study is to explore hypolipidemic and hepatoprotective activities of the brown seaweed Iyengariastellata. Ethanolic extract of seaweed was suspended in distilled water and administered orally at 10mg/200g body weight to rabbits for 30 days and total lipid level, cholesterol, triglycerides, HDL, LDL, VLDL, alkaline phosphatase, SGPT, SGOT, Gamma GT were assessed. The results showed overall decrease in lipid profile whereas Iyengariastellata  increased liver enzymes except SGPT which was decreased highly significantly, since SGPT is more specific indicator of liver injury, decreased value of SGPT indicates that Iyengariastellata  toxicity is less severe and reversible with marked hypolipidemic effect, but during the course of ingestion of the seaweed the liver enzymes must be carefully monitored to ensure liver safety.
Publication Details
Page(s) 1775-1779
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 27, Issue: 6, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

77

Views